Chosa Oncology
0.84 SEK
-4.55 %
Less than 1K followers
CHOSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-4.55 %
-26.32 %
-32.26 %
+31.25 %
+6.94 %
+27.66 %
-21.25 %
-96.64 %
-93.34 %
Chosa Oncology is a Swedish-Danish biotechnology company that develops solutions for personalized cancer treatment with a focus on diagnostics and drug formulation. The company targets healthcare providers and research actors and works internationally with partners and clinical projects. Chosa Oncology was founded in 2022 and is headquartered in Lund, Sweden.
Read moreMarket cap
66.27M SEK
Turnover
43.33K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
27/5
2026
General meeting '26
All
Press releases
ShowingAll content types
Chosa Oncology AB: CHOSA - The market now doubles for Platin-DRP®, which predicts overall survival in lung cancer patients based on NanoString data
Chosa Oncology AB: CHOSA Oncology AB - Kvartalsrapport juli-sept 2025.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools